Aimei Health Technology Co., Ltd
AFJK
$12.03
-$0.25-2.04%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 362.26% | -85.00% | -37.66% | -34.90% | -86.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 362.26% | -85.00% | -37.66% | -34.90% | -86.54% |
| Operating Income | -362.26% | 85.00% | 37.66% | 34.90% | 86.54% |
| Income Before Tax | -119.55% | -75.42% | -77.91% | -52.66% | -30.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -119.55% | -75.42% | -77.91% | -52.66% | -30.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -119.55% | -75.42% | -77.91% | -52.66% | -30.22% |
| EBIT | -362.26% | 85.00% | 37.66% | 34.90% | 86.54% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -137.90% | -43.31% | -61.59% | -30.22% | 2.81% |
| Normalized Basic EPS | -137.79% | -43.04% | -61.69% | -30.29% | 2.84% |
| EPS Diluted | -137.90% | -43.31% | -61.59% | -30.22% | 2.81% |
| Normalized Diluted EPS | -137.79% | -43.04% | -61.69% | -30.29% | 2.84% |
| Average Basic Shares Outstanding | -48.28% | -56.53% | -42.62% | -32.18% | -32.18% |
| Average Diluted Shares Outstanding | -48.28% | -56.53% | -42.62% | -32.18% | -32.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |